Across the Australian research landscape, small genome projects are pushing their heads above the ground. [ + ]

Canada was one of the first countries to hop on the genomics bandwagon after the human genome project was completed. Since 2001, the Canadian federal government has invested C$386 million into Genome Canada, an independently operated organisation with the role of coordinating and funding genomics and proteomics research across Canada. [ + ]

Susan Williamson discovers why the theme of tissue architecture is so prominent at this year's Lorne Cancer conference. [ + ]

As with any emerging science there is some controversy regarding nomenclature, but the newly formed Metabolomics Society seems to be adhering to a convention consistent with the other '-omic' sciences

Are there some personalities that are better suited than others to a scientific career? To provide insight into this issue, The Science Advisory Board created the first-ever psychological profile of life science researchers

Vaxine's Nikolai Petrovsky says peptide vaccines work well in highly inbred laboratory mice, but have consistently failed in clinical trials over the past two decades because humans are an outbred species. [ + ]

Several Australian companies are trialling new 'natural' and synthetic adjuvants that combine potent immuno-stimulatory activity with low toxicity. Australia's biggest biotech, Melbourne's CSL (ASX:CSL), is boosting its experimental vaccines with its Iscomatrix adjuvant system, a phospholipid-cholesterol formulation containing a purified saponin extract from the bark of the South American tree Quillaja saponaria. [ + ]

Shakespeare's witches, in 'Macbeth', were concocting mischief, not some nostrum to ward off plague, but some of the things that imbue today's vaccines with immunogenic fizz would not have been misplaced among the eldritch ingredients in their cauldron. [ + ]

Some Australian biotechs are getting creative with company structure. But analysts prefer their companies to play it straight. [ + ]

I'm a statistician. I don't know a mass spectrometer from a resonating horoscope. But it seems to me that many practitioners and researchers do not have an optimal balance between the various stages of their data collection

In a recent project, electrophysiology researchers at Westmead Hospital in Sydney required a system to acquire and analyse signals measured using a micro-electrode array

How effective LIMS software design can leverage evolving technologies to reduce risk and improve ROI. As the commercial LIMS marketplace evolves and matures, it continually faces the challenge of technology change

Researchers at the University of California, Riverside have discovered the world's strongest acid. Remarkably it is also the gentlest acid

Australian venture capitalists invested more than $1 million per week in Australian biotechnology in the past financial year, an increase on the previous year and a recovery to the historic level of two years ago. As in the past, a large portion of the investment was made by a small number of investors, and was received by a small number of investees. [ + ]

When Francis Crick and James Watson deciphered the structure of DNA in 1953, x-ray crystallography became famous. X-ray crystallography has long since become the workhorse for structural studies of big biological molecules